Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates (OIDS)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by OSF Healthcare System.
Recruitment status was  Not yet recruiting
Study NCT00961753   Information provided by OSF Healthcare System

First Received on August 18, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Patent Ductus Arteriosus
Additional conditions recognized in this trial
Ductus Arteriosus, Patent
More general conditions related to this trial
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Heart Defects, Congenital
Heart Diseases
Interventions listed in this trial
optimized ibuprofen
Standard Ibuprofen
Additional drug interventions recognized in this trial
Ibuprofen
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
OSF Healthcare System


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services